Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
368,659,889
-
Total 13F shares
-
63,494,614
-
Share change
-
-941,512
-
Total reported value
-
$3,169,508,515
-
Put/Call ratio
-
31%
-
Price per share
-
$49.92
-
Number of holders
-
167
-
Value change
-
-$28,958,118
-
Number of buys
-
86
-
Number of sells
-
72
Institutional Holders of Legend Biotech Corp - Ordinary Shares (LEGN) as of Q4 2022
As of 31 Dec 2022,
Legend Biotech Corp - Ordinary Shares (LEGN) was held by
167 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
63,494,614 shares.
The largest 10 holders included
FMR LLC, HHLR ADVISORS, LTD., BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., Capital World Investors, FEDERATED HERMES, INC., Capital International Investors, JANUS HENDERSON GROUP PLC, WELLINGTON MANAGEMENT GROUP LLP, and JOHNSON & JOHNSON.
This page lists
167
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.